2025
Pfizer's annual revenue
was
$62.58 B
in
fiscal year 2025.
Pfizer's quarterly revenue was $13.72 B(Q1: Mar 2025), $14.65 B(Q2: Jun 2025), $16.65 B(Q3: Sep 2025), $17.56 B(Q4: Dec 2025) in fiscal year 2025.
... See more
2024
Pfizer's annual revenue
was
$63.63 B
in
fiscal year 2024.
Pfizer's quarterly revenue was $14.88 B(Q1: Mar 2024), $13.28 B(Q2: Jun 2024), $17.70 B(Q3: Sep 2024), $17.76 B(Q4: Dec 2024) in fiscal year 2024.
2023
Pfizer's annual revenue
was
$59.55 B
in
fiscal year 2023.
Pfizer's quarterly revenue was $18.49 B(Q1: Apr 2023), $13.01 B(Q2: Jul 2023), $13.49 B(Q3: Oct 2023), $14.57 B(Q4: Dec 2023) in fiscal year 2023.
2022
Pfizer's annual revenue
was
$100.33 B
in
fiscal year 2022.
Pfizer's quarterly revenue was $25.66 B(Q1: Apr 2022), $27.74 B(Q2: Jul 2022), $22.64 B(Q3: Oct 2022), $24.29 B(Q4: Dec 2022) in fiscal year 2022.
2021
Pfizer's annual revenue
was
$81.29 B
in
fiscal year 2021.
Pfizer's quarterly revenue was $14.52 B(Q1: Apr 2021), $18.90 B(Q2: Jul 2021), $24.04 B(Q3: Oct 2021), $23.84 B(Q4: Dec 2021) in fiscal year 2021.
2020
Pfizer's annual revenue
was
$41.65 B
in
fiscal year 2020.
Pfizer's quarterly revenue was $10.08 B(Q1: Mar 2020), $9.86 B(Q2: Jun 2020), $10.28 B(Q3: Sep 2020), $11.63 B(Q4: Dec 2020) in fiscal year 2020.
2019
Pfizer's annual revenue
was
$41.17 B
in
fiscal year 2019.
Pfizer's quarterly revenue was $13.12 B(Q1: Mar 2019), $13.26 B(Q2: Jun 2019), $12.68 B(Q3: Sep 2019), $12.69 B(Q4: Dec 2019) in fiscal year 2019.
2018
Pfizer's annual revenue
was
$53.65 B
in
fiscal year 2018.
Pfizer's quarterly revenue was $12.91 B(Q1: Apr 2018), $13.47 B(Q2: Jul 2018), $13.30 B(Q3: Sep 2018), $13.98 B(Q4: Dec 2018) in fiscal year 2018.
2017
Pfizer's annual revenue
was
$52.55 B
in
fiscal year 2017.
Pfizer's quarterly revenue was $12.78 B(Q1: Apr 2017), $12.90 B(Q2: Jul 2017), $13.17 B(Q3: Oct 2017), $13.70 B(Q4: Dec 2017) in fiscal year 2017.
2016
Pfizer's annual revenue
was
$52.82 B
in
fiscal year 2016.
Pfizer's quarterly revenue was $13.01 B(Q1: Apr 2016), $13.15 B(Q2: Jul 2016), $13.05 B(Q3: Oct 2016), $13.63 B(Q4: Dec 2016) in fiscal year 2016.